<SEC-DOCUMENT>0000917520-22-000029.txt : 20220719
<SEC-HEADER>0000917520-22-000029.hdr.sgml : 20220719
<ACCEPTANCE-DATETIME>20220719162036
ACCESSION NUMBER:		0000917520-22-000029
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20220718
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220719
DATE AS OF CHANGE:		20220719

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTEGRA LIFESCIENCES HOLDINGS CORP
		CENTRAL INDEX KEY:			0000917520
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				510317849
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26224
		FILM NUMBER:		221091798

	BUSINESS ADDRESS:	
		STREET 1:		1100 CAMPUS ROAD
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540
		BUSINESS PHONE:		6092750500

	MAIL ADDRESS:	
		STREET 1:		1100 CAMPUS ROAD
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTEGRA LIFESCIENCES CORP
		DATE OF NAME CHANGE:	19950614
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>iart-20220718.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:cbb5b175-68b1-4695-907f-f3ae3e40a02f,g:71eabf76-08c3-4a66-896a-3d8217fba004,d:e7200c9c70a942b8b1cd617041f51000--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>iart-20220718</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF80L2ZyYWc6NmQ5ZjIyNjlmZTg3NDllNmJlNzA3NDc3ZDNmOGJkMTEvdGFibGU6ZmRkYzIzZTJiZTJjNDkwNDkzMjNlZDY0MWQxOTAxNmQvdGFibGVyYW5nZTpmZGRjMjNlMmJlMmM0OTA0OTMyM2VkNjQxZDE5MDE2ZF8yLTEtMS0xLTExNTI2Nw_6ca8d71f-0b09-453e-8d25-becac67fb64b">0000917520</ix:nonNumeric><ix:nonNumeric contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF80L2ZyYWc6NmQ5ZjIyNjlmZTg3NDllNmJlNzA3NDc3ZDNmOGJkMTEvdGFibGU6ZmRkYzIzZTJiZTJjNDkwNDkzMjNlZDY0MWQxOTAxNmQvdGFibGVyYW5nZTpmZGRjMjNlMmJlMmM0OTA0OTMyM2VkNjQxZDE5MDE2ZF81LTEtMS0xLTExNTI2Nw_db69a86f-070b-457e-b264-8378c27858be">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="iart-20220718.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000917520</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-18</xbrli:startDate><xbrli:endDate>2022-07-18</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ie7200c9c70a942b8b1cd617041f51000_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13.5pt;font-weight:400;line-height:120%">Washington, D.C. 20549 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8xNzQy_4da1b1c6-195c-4fdb-9f14-80be2fa9f16a">8-K</ix:nonNumeric> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section 13 or 15(d) of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Securities Exchange Act of 1934 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8yMzM_b0a6fe15-deb8-44fe-8e1f-9424d2e4d4aa">July 18, 2022</ix:nonNumeric> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8xNzM1_d49c437d-07cb-4f80-8bcb-cf3e8feee66f">INTEGRA LIFESCIENCES HOLDINGS CORP</ix:nonNumeric>ORATION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of Registrant as specified in its charter) </span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.023%"><tr><td style="width:1.0%"></td><td style="width:40.015%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.686%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGFibGU6MDMzMjZiOWQyYzZlNGMwZjk2YWZmMTE2YjU1YmJjZDEvdGFibGVyYW5nZTowMzMyNmI5ZDJjNmU0YzBmOTZhZmYxMTZiNTViYmNkMV8wLTAtMS0xLTExNTI2Nw_bd0252cf-00b2-4701-8d07-9b9e8862ac5e">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGFibGU6MDMzMjZiOWQyYzZlNGMwZjk2YWZmMTE2YjU1YmJjZDEvdGFibGVyYW5nZTowMzMyNmI5ZDJjNmU0YzBmOTZhZmYxMTZiNTViYmNkMV8wLTEtMS0xLTExNTI2Nw_59a97d02-2a35-452d-a6ab-b4b88d086694">0-26224</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGFibGU6MDMzMjZiOWQyYzZlNGMwZjk2YWZmMTE2YjU1YmJjZDEvdGFibGVyYW5nZTowMzMyNmI5ZDJjNmU0YzBmOTZhZmYxMTZiNTViYmNkMV8wLTItMS0xLTExNTI2Nw_79d12c06-f5f5-48c5-b8d0-b0fc9bde8f6a">51-0317849</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of  incorporation or organization) </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8xNzM2_7f83a22e-bd79-489f-9ae0-b1dca13516ba">1100 Campus Road</ix:nonNumeric>  </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8xNzM3_da1efb9d-6fc7-4f06-8844-afe6cc63ea28">Princeton</ix:nonNumeric>, <ix:nonNumeric contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8xNzM4_e3041664-a8d8-4cb5-badd-c944a2c6d512">NJ</ix:nonNumeric> <ix:nonNumeric contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8xNzQz_4a9fdcf0-6742-4dea-af58-d48b86605aa9">08540</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices) (Zip Code) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code: (<ix:nonNumeric contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8xNzM5_35b04fe6-51bb-4035-aac7-7e16e73e929c">609</ix:nonNumeric>) <ix:nonNumeric contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8xNzQ0_8473a5bc-891b-4d4a-8c03-223ccc2d0be7">275-0500</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report) </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8xNzQ1_a59fbb9e-473e-484b-967f-ebde86be278f">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8xNzQw_10cbb97d-a537-4234-b5d1-d9653f57bf04">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8xNzQ2_8007c07a-e25a-43e8-a850-5641464baa12">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR   240.14d-2(b))</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8xNzQx_f44ce828-4a91-475e-8534-b01b7642d7f6">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div><span><br/></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities Registered Pursuant to Section12(b) of the Act:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">  </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.953%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.793%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.954%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Title of Each Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Name of Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGFibGU6MzBjM2MyYmZjOTJkNDdjNmI5Zjc4M2ZkN2Y2ZmY4ZTkvdGFibGVyYW5nZTozMGMzYzJiZmM5MmQ0N2M2YjlmNzgzZmQ3ZjZmZjhlOV8xLTAtMS0xLTExNTI2Nw_3154d3e0-bf29-4c6c-bcef-e9c97478257b">Common Stock, Par Value $.01 Per Share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGFibGU6MzBjM2MyYmZjOTJkNDdjNmI5Zjc4M2ZkN2Y2ZmY4ZTkvdGFibGVyYW5nZTozMGMzYzJiZmM5MmQ0N2M2YjlmNzgzZmQ3ZjZmZjhlOV8xLTEtMS0xLTExNTI2Nw_fce9638b-8598-4992-bd18-013f35c8a50f">IART</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGFibGU6MzBjM2MyYmZjOTJkNDdjNmI5Zjc4M2ZkN2Y2ZmY4ZTkvdGFibGVyYW5nZTozMGMzYzJiZmM5MmQ0N2M2YjlmNzgzZmQ3ZjZmZjhlOV8xLTItMS0xLTExNTI2Nw_af34c435-1146-4553-b627-c4a98b8d3739">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8xNzQ3_2bdc1e12-48d0-444e-b964-5e8093172582">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ie7200c9c70a942b8b1cd617041f51000_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On July 18, 2022, the Board of Directors (&#8220;Board&#8221;) of Integra LifeSciences Holdings Corporation (the &#8220;Company&#8221;) appointed Renee Wonlai Lo as a director of the Company, effective immediately, to fill an existing vacancy on the Board. The Board has determined that Ms. Lo is &#8220;independent&#8221; as contemplated by the Nasdaq Stock Market and other governing laws and applicable regulations, including Rule 10A-3 under the Securities Exchange Act of 1934, as amended. Ms. Lo is not serving on any standing committees of the Board at this time.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In connection with her appointment to the Board, pursuant to the Company&#8217;s non-employee director compensation policy, Ms. Lo will be eligible to receive an annual retainer and a director equity grant, in each case as described under &#8220;Director Compensation &#8211; Compensation&#8221; in the Company&#8217;s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 8, 2022. The initial annual board retainer to be received by Ms. Lo will be pro-rated </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">based on her appointment as of July 18, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In connection with her appointment to the Board, the Company and Ms. Lo will enter into an indemnification agreement consistent with the form of the Company&#8217;s indemnification agreement entered into with its other directors, the form of which is filed as Exhibit 10.1 to this Current Report on Form 8-K. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other than as described above, there were no arrangements or understandings between Ms. Lo and any other persons pursuant to which she was selected as a director, and neither Ms. Lo nor any of her immediate family has been a party to any transaction or currently proposed transaction with the Company that is reportable under Item 404(a) of Regulation S-K.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A press release announcing Ms. Lo&#8217;s appointment was issued on July 19, 2022. A copy of such press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.</span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d) Exhibits</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.188%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.612%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex101indemnificationagreem.htm">Form of Indemnification Agreement, by and between Integra LifeSciences Holdings Corporation and each of its directors and executive officers.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">99.1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="pressreleasereneelo.htm">Press Release, dated July 19, 2022, issued by Integra LifeSciences Holdings Corporation.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cover Page Interactive Data File (embedded within the inline XRBL document).</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ie7200c9c70a942b8b1cd617041f51000_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:  July 19, 2022</span></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;/s/ Eric I. Schwartz</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eric I. Schwartz</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:279pt;text-indent:-279pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Legal Officer and</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Secretary</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex101indemnificationagreem.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i4ea4fac8b94941efb9d9fa4774be829d_38"></div><div style="min-height:74.88pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibit 10.1</font></div><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">INDEMNIFICATION AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Indemnification Agreement (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is made as of __________________, _______ by and between Integra LifeSciences Holdings Corporation, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and ____________________ (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnitee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  This Agreement supersedes and replaces any and all previous agreements between the Company and Indemnitee covering the subject matter of this Agreement.</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RECITALS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, directors, officers, and other persons in service to publicly-held corporations and other business enterprises are subjected to expensive and time-consuming litigation relating to, among other things, matters that traditionally would have been brought only against the corporation or business enterprise itself&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, in light of the litigation costs and risks, highly competent persons are likely to be reluctant to serve as directors or in other capacities of publicly-held corporations without adequate protection through insurance and indemnification against litigation costs and risks arising out of their service to and activities on behalf of the corporation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, the Board of Directors of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) has determined that, in order to attract and retain qualified individuals to serve the Company, the Company will attempt to maintain on an ongoing basis, at its sole expense, liability insurance for the benefit of such persons&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, the General Corporation Law of the State of Delaware (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">DGCL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) permits, and the By-laws of the Company require, indemnification of the officers and directors of the Company&#59; each expressly provides that the indemnification provisions set forth therein are not exclusive, and thereby contemplate that contracts may be entered into between the Company and members of the Board, officers and other persons with respect to indemnification&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, it is reasonable, prudent and necessary for the Company to obligate itself contractually to indemnify, and to advance expenses on behalf of, such persons to the fullest extent permitted by applicable law so that they will serve or continue to serve the Company free from undue concern regarding the abovementioned litigation costs and risks&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, the Company desires Indemnitee to serve (or continue to serve) as an officer or director (and may have requested or may request in the future that Indemnitee serve the Enterprise (as defined below) in other capacities)&#59; in order to induce Indemnitee to serve (or continue to serve) in such capacity, the Company is entering into this Agreement&#59; the indemnification provisions of this Agreement are a supplement to and in furtherance of the By-laws of the Company (and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder)&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, Indemnitee is willing to serve or continue to serve as a director, officer or in another capacity, as applicable, on the condition that Indemnitee be so indemnified. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the premises and the covenants contained herein, the Company and Indemnitee do hereby covenant and agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:28.03pt;text-decoration:underline">Services to the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Indemnitee agrees to serve, or continue to serve, as a director, officer, employee and Agent (as defined below) of the Company and&#47;or, as applicable, its subsidiaries and any Enterprise (as defined below).  Indemnitee may at any time and for any reason resign from any such position (subject to any other contractual obligation or any obligation imposed by operation of law), in which event the Company shall have no obligation under this Agreement to continue Indemnitee in such position.  This Agreement shall not be deemed an employment contract between the </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Company (or any of its subsidiaries or any Enterprise) and Indemnitee.  Indemnitee specifically acknowledges that Indemnitee&#8217;s employment with the Company (or any of its subsidiaries or any Enterprise), if any, is at will, and Indemnitee may be discharged at any time for any reason, with or without cause, except as may be otherwise provided in any written employment contract between Indemnitee and the Company (or any such subsidiary or Enterprise), other applicable formal severance policies duly adopted by the Board, or, with respect to service as a director or officer of the Company, by the Company&#8217;s Certificate of Incorporation, the Company&#8217;s By-laws and the DGCL.  The foregoing notwithstanding, this Agreement shall continue in force after Indemnitee has ceased to serve as a director, officer, employee and Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">of the Company or any of its subsidiaries or other Enterprise as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:28.03pt;text-decoration:underline">Certain Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.   As used in this Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean any person who is or was a director, officer or employee of the Company or other person authorized by the Company to act for the Company, to include any person serving in such capacity as a director, officer, employee, fiduciary or other official of another corporation, partnership, limited liability company, joint venture, trust, employee benefit plan or other Enterprise (including any subsidiary of the Company) at the request of, for the convenience of, or to represent the interests of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">A &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall be deemed to occur upon the earliest to occur after the date of this Agreement of any of the following events&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:75.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:27pt">Acquisition of Stock by Third Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Any Person (as defined below), other than Richard E. Caruso, Ph.D., Provco Leasing Corporation or Tru St Partnership, L.P., is or becomes the Beneficial Owner (as defined below), directly or indirectly, of securities of the Company representing fifteen percent (15%) or more of the combined voting power of the Company&#8217;s then outstanding securities&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:27pt">Change in Board of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  During any period of two (2) consecutive years (not including any period prior to the execution of this Agreement), individuals who at the beginning of such period constitute the Board, and any new director (other than a director designated by a person who has entered into an agreement with the Company to effect a transaction described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 2(b)(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2(b)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">2(b)(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereof) whose election by the Board or nomination for election by the Company&#8217;s stockholders was approved by a vote of at least two-thirds of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority of the members of the Board&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:69.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:27pt">Corporate Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The effective date of a merger or consolidation of the Company with any other entity, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior to such merger or consolidation continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than 51% of the combined voting power of the voting securities of the surviving entity outstanding immediately after such merger or consolidation and with the power to elect at least a majority of the board of directors or other governing body of such surviving entity&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:69.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:27pt">Liquidation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The approval by the stockholders of the Company of a complete liquidation of the Company or an agreement for the sale or disposition by the Company of all or substantially all of the Company&#8217;s assets&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:27pt">Other Events</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  There occurs any other event of a nature that would be required to be reported in response to Item 6(e) of Schedule 14A of Regulation 14A (or a response to any similar item on any similar schedule or form) promulgated under the Exchange Act (as defined below), whether or not the Company is then subject to such reporting requirement.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">-2-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;For purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the following terms shall have the following meanings&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Securities Exchange Act of 1934, as amended from time to time.</font></div><div style="margin-bottom:12pt;padding-left:72pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning as set forth in Sections 13(d) and 14(d) of the Exchange Act&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that Person shall exclude (i) the Company, (ii) any trustee or other fiduciary holding securities under an employee benefit plan of the Company, and (iii) any corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company.  </font></div><div style="margin-bottom:12pt;padding-left:72pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Beneficial Owner</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall have the meaning given to such term in Rule 13d-3 under the Exchange Act&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that Beneficial Owner shall exclude any Person otherwise becoming a Beneficial Owner by reason of the stockholders of the Company approving a merger of the Company with another entity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Corporate Status</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; describes the status of a person who is or was a director, officer, employee or Agent of the Company or any other corporation, limited liability company, partnership or joint venture, trust, employee benefit plan or other Enterprise, in which capacity such person is or was serving at the request of, for the convenience of, or to represent the interests of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Disinterested Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean a director of the Company who is not and was not a party to the Proceeding in respect of which indemnification is sought by Indemnitee.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Enterprise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the Company and any other corporation, limited liability company, partnership, joint venture, trust, employee benefit plan or other enterprise (including any subsidiary of the Company) of which Indemnitee is or was serving as a director, officer, employee or Agent at the request of, for the convenience of, or to represent the interests of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall include all reasonable attorneys&#8217; fees, retainers, court costs, transcript costs, fees of experts, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, any federal, state, local or foreign taxes imposed on Indemnitee as a result of the actual or deemed receipt of any payments under this Agreement, ERISA excise taxes and penalties, and all other disbursements or expenses of the types customarily incurred in connection with or as a result of prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to be a deponent or witness in, or otherwise participating in, a Proceeding.  Expenses also shall include, without limitation&#58; (i) expenses incurred in connection with any appeal resulting from any Proceeding, including without limitation the premium, security for, and other costs relating to any cost bond, supersedeas bond, or other appeal bond or its equivalent, and (ii) for purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 14(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, expenses incurred by Indemnitee in connection with the interpretation, enforcement or defense of Indemnitee&#8217;s rights under this Agreement, by litigation or otherwise.  Expenses, however, shall not include amounts paid in settlement by Indemnitee or the amount of judgments or fines against Indemnitee.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Independent Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean a law firm, or a member of a law firm, that is experienced in matters of corporate law and neither presently is, nor in the past five (5) years has been, retained to represent&#58;  (i) the Company or Indemnitee in any matter material to either such party (other than with respect to matters concerning Indemnitee&#8217;s right to indemnification under this Agreement, or of other indemnitees under similar indemnification agreements with the Company), or (ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder.  Notwithstanding the foregoing, the term &#8220;Independent Counsel&#8221; shall not include any law firm or member of a law firm who, under the applicable standards of professional conduct, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee&#8217;s rights under this Agreement.  The Company agrees to pay the reasonable fees and expenses of the Independent Counsel referred to above </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">-3-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">and to indemnify such counsel fully against any and all expenses, claims, liabilities and damages arising out of or relating to this Agreement or its engagement pursuant hereto.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">The term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Proceeding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall include any threatened, pending or completed action, suit, arbitration, mediation, alternate dispute resolution process, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding, whether brought by or in the right of the Company or otherwise, and whether of a civil, criminal, administrative, regulatory, legislative or investigative (formal or informal) nature, including any appeal therefrom, in which Indemnitee was, is or could be involved as a party, potential party, non-party witness or otherwise by reason of the fact that Indemnitee is or was a director, officer, employee or Agent of the Company and&#47;or any other Enterprise, by reason of any action taken by him or of any action on his part while acting as a director, officer, employee or Agent of the Company and&#47;or such other Enterprise, in each case whether or not serving in such capacity at the time any liability or expense is incurred for which indemnification, reimbursement, or advancement of expenses can be provided under this Agreement.  If the Indemnitee believes in good faith that a given situation may lead to or culminate in the institution of a Proceeding, such situation shall be considered a Proceeding under this paragraph.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.63pt">References to &#8220;fines&#8221; shall include any excise tax assessed with respect to any employee benefit plan&#59; references to &#8220;serving at the request of the Company&#8221; shall include any service as a director, officer, employee or Agent of the Company that imposes duties on, or involves services by, such director, officer, employee or Agent with respect to an employee benefit plan, its participants or beneficiaries&#59; and a person who acted in good faith and in a manner he reasonably believed to be in the best interests of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in manner &#8220;not opposed to the best interests of the Company&#8221; as referred to in this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:28.03pt;text-decoration:underline">Indemnity in Third-Party Proceedings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Company shall indemnify Indemnitee in accordance with the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding, other than a Proceeding by or in the right of the Company to procure a judgment in its favor.  Pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, Indemnitee shall be indemnified to the fullest extent permitted by applicable law against all Expenses, judgments, fines and amounts paid in settlement actually and reasonably incurred by Indemnitee or on his behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner he reasonably believed to be in, or not opposed to, the best interests of the Company and, in the case of a criminal action or proceeding, had no reasonable cause to believe that his conduct was unlawful.  The parties hereto intend that this Agreement shall provide to the fullest extent permitted by law for indemnification in excess of that expressly permitted by statute, including, without limitation, any indemnification provided by the Company&#8217;s Certificate of Incorporation, its By-Laws, vote of its stockholders or Disinterested Directors (or any committee thereof), or applicable law.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:28.03pt;text-decoration:underline">Indemnity in Proceedings by or in the Right of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.   The Company shall indemnify Indemnitee in accordance with the provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding by or in the right of the Company to procure a judgment in its favor.  Pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, Indemnitee shall be indemnified to the fullest extent permitted by applicable law against all Expenses actually and reasonably incurred by him or on his behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the Company&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that no indemnification for Expenses shall be made under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> in respect of any claim, issue or matter as to which Indemnitee shall have been finally adjudged by a court of competent jurisdiction to be liable to the Company, unless and only to the extent that the Delaware Court of Chancery or any court in which the Proceeding was brought or is pending shall determine upon application that, despite the adjudication of liability and in view of all the circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnification for such Expenses that the Delaware Court of Chancery or such other court deems proper.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:28.03pt;text-decoration:underline">Indemnification for Expenses of a Party Who is Wholly or Partially Successful</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Notwithstanding any other provision of the Agreement, to the fullest extent permitted by applicable law and to the extent that Indemnitee is a party to (or a participant in) and is successful, on the merits or </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">-4-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">otherwise, in any Proceeding (including, without limitation, any Proceeding brought by or in right of the Company) or in defense of any claim, issue or matter therein, in whole or in part, the Company shall indemnify Indemnitee against all Expenses actually and reasonably incurred by him in connection therewith.  If Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all applicable claims, issues or matters in such Proceeding, the Company shall indemnify Indemnitee against all Expenses actually and reasonably incurred by him or on his behalf in connection with or related to each successfully resolved claim, issue or matter to the fullest extent permitted by law.  For purposes of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and without limitation, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim, issue or matter.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:28.03pt;text-decoration:underline">Indemnification for Expenses of a Witness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  To the fullest extent permitted by applicable law and to the extent that Indemnitee is, by reason of his Corporate Status, a witness, is forced to respond to discovery requests, or is otherwise asked to participate in any Proceeding to which Indemnitee is not a party, the Company shall indemnify him against, and advance as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereof, all Expenses actually and reasonably incurred by him or on his behalf in connection therewith.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:28.03pt;text-decoration:underline">Partial Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If Indemnitee is entitled under any provision of this Agreement to indemnification by the Company for some or a portion of Expenses, but not, however, for the total amount thereof, the Company shall nevertheless indemnify Indemnitee for the portion thereof to which Indemnitee is entitled.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:28.03pt;text-decoration:underline">Additional Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Notwithstanding any limitation in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereof, the Company shall indemnify Indemnitee to the fullest extent permitted by applicable law if Indemnitee is a party to or threatened to be made a party to any Proceeding (including a Proceeding by or in the right of the Company to procure a judgment in its favor) against all Expenses, judgments, fines and amounts paid in settlement actually and reasonably incurred by Indemnitee in connection with the Proceeding.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">For purposes of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the meaning of the phrase &#8220;to the fullest extent permitted by applicable law&#8221; shall include, but not be limited to, the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:75.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27pt">to the fullest extent permitted by the provision of the DGCL that authorizes or contemplates additional indemnification by agreement, or the corresponding provision of any amendment to or replacement of the DGCL, and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27pt">to the fullest extent authorized or permitted by any amendments to or replacements of the DGCL adopted after the date of this Agreement that increase the extent to which a Delaware corporation may indemnify its directors, officers, employees, and Agents of the Company or any of its subsidiaries.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:28.03pt;text-decoration:underline">Exclusions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.   Notwithstanding any other provision in this Agreement, the Company shall not be obligated to indemnify Indemnitee in connection with any claim against Indemnitee&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">to the extent that payment has actually been made to or on behalf of Indemnitee under any insurance policy or other indemnity provision&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">for (i) an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company within the meaning of Section 16(b) of the Exchange Act (as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereof) or similar provisions of state statutory law or common law, or (ii) any reimbursement of the Company by Indemnitee of any bonus or other incentive-based or equity-based compensation or of any profits realized by Indemnitee from the sale of securities of the Company, as required in each case under the Exchange Act (including any such reimbursements that arise from an accounting restatement of the Company pursuant to Section 304 of the Sarbanes-Oxley Act of </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">-5-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2002 (as amended, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sarbanes-Oxley Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), or the payment to the Company of profits arising from the purchase and sale by Indemnitee of securities in violation of Section 306 of the Sarbanes-Oxley Act)&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">in connection with any Proceeding (or any part of any Proceeding) initiated by Indemnitee, including any Proceeding (or any part of any Proceeding) initiated by Indemnitee against the Company or its directors, officers, employees or other indemnitees, unless (i) the Board authorized the Proceeding (or such part of such Proceeding) prior to its initiation or (ii) the Company provides the indemnification, in its sole discretion, pursuant to the powers vested in the Company under applicable law&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that this provision shall not apply to any claims related to the interpretation, enforcement or defense of Indemnitee&#8217;s rights under this Agreement by litigation or otherwise, including as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">14(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Advances of Expenses.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">   In furtherance and not in limitation of the provisions of Section 6.02 of the By-laws of the Company, and notwithstanding any other provision of this Agreement to the contrary, the Company shall advance on a current and as-incurred basis, to the extent not prohibited by law, the Expenses incurred by Indemnitee in connection with any Proceeding, and such advancement shall be made within thirty (30) days after the receipt by the Company of a properly submitted written statement or statements requesting such advances pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, whether prior to or after final disposition of any Proceeding.  Advances shall be unsecured and interest free.  Advances shall be made without regard to Indemnitee&#8217;s ability to repay the Expenses and without regard to Indemnitee&#8217;s ultimate entitlement to indemnification under the other provisions of this Agreement.  Advances shall include any and all reasonable Expenses incurred by Indemnitee in pursuing an action to enforce this right of advancement, including Expenses incurred preparing and forwarding statements to the Company to support the advances claimed.  Indemnitee shall qualify for advances upon the execution and delivery to the Company of this Agreement, which shall constitute an undertaking by Indemnitee to repay (without interest) the amounts advanced to the extent that it is ultimately determined that Indemnitee is not entitled to be indemnified by the Company, and no other form of undertaking shall be required from Indemnitee other than the execution of this Agreement.  This </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall not apply to any claim made by Indemnitee for which indemnity is otherwise excluded pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Procedure for Notification and Defense of Claim.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Indemnitee shall notify the Company in writing of any matter with respect to which Indemnitee intends to seek indemnification or advancement of Expenses hereunder as soon as reasonably practicable following the receipt by Indemnitee of written notice thereof or Indemnitee&#8217;s becoming aware thereof (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Indemnification Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  The Indemnification Notice shall include a description of the nature of the Proceeding and the facts underlying the Proceeding, in each case to the extent known to Indemnitee.  To obtain indemnification under this Agreement, Indemnitee shall also submit to the Company such documentation and information as is reasonably available to Indemnitee and is reasonably necessary to determine whether and to what extent Indemnitee is entitled to indemnification following the final disposition of such Proceeding.  The omission by Indemnitee to notify the Company hereunder will not relieve the Company from any liability which it may have to Indemnitee under this Agreement or otherwise, and any delay in so notifying the Company shall not constitute a waiver by Indemnitee of any rights under this Agreement.  The Secretary of the Company shall, promptly upon receipt of the Indemnification Notice, advise the Board in writing that Indemnitee has requested indemnification and&#47;or advancement of Expenses.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">The Company will be entitled to participate in the Proceeding at its own expense.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Procedure Upon Application for Indemnification.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Upon delivery of the Indemnification Notice by Indemnitee under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, a determination, if required by applicable law, with respect to Indemnitee&#8217;s entitlement thereto shall be made with respect to such request as follows&#58;  (i) by a majority vote of the Disinterested Directors, even though less than a quorum of the Board, (ii) by a committee of Disinterested Directors designated by a majority vote of the Disinterested Directors, even though less than a quorum of the Board, (iii) if there are no such Disinterested Directors or, if such Disinterested Directors so direct, by Independent Counsel in a </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">-6-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">written opinion to the Board, a copy of which shall be delivered to Indemnitee or (iv) if so directed by the Board, by the stockholders of the Company&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided, however, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that, notwithstanding the foregoing, in all cases, Indemnitee shall have the option, but not the obligation, to require, by delivery of a written request to the Company, that the determination with respect to Indemnitee&#8217;s entitlement to indemnification hereunder be made by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee (in which case such request shall be made prior to any determination by the Disinterested Directors (or any committee thereof) or prior to the submission of such matter to a vote by the stockholders of the Company).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">If it is determined pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereof that Indemnitee is entitled to indemnification, payment to Indemnitee shall be made within ten (10) days after such determination.  Indemnitee shall cooperate with the person, persons or entity making such determination with respect to Indemnitee&#8217;s entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance written request any documentation or information that is not privileged or otherwise protected from disclosure and that is reasonably available to Indemnitee and reasonably necessary to such determination.  Any Expenses incurred by Indemnitee in so cooperating with the person, persons or entity making such determination shall be borne by the Company (irrespective of the determination as to Indemnitee&#8217;s entitlement to indemnification) and the Company hereby indemnifies and agrees to hold Indemnitee harmless therefrom.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">In the event the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereof, the Independent Counsel shall be selected as provided in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;12(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If a Change in Control shall have occurred or if Indemnitee otherwise elects to require determination with respect to Indemnitee&#8217;s entitlement to indemnification hereunder to be made by Independent Counsel, the Independent Counsel shall be selected by Indemnitee (unless Indemnitee shall request that such selection be made by the Board, in which event the following sentence shall apply), and Indemnitee shall give written notice to the Company advising it of the identity of the Independent Counsel so selected.  If a Change in Control shall not have occurred and the determination with respect to Indemnitee&#8217;s entitlement to indemnification hereunder is to be made by Independent Counsel pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12(a)(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or if Indemnitee shall otherwise request, the Independent Counsel shall be selected by the Board, and the Company shall give written notice to Indemnitee advising him of the identity of the Independent Counsel so selected.  In either event, Indemnitee or the Company, as the case may be, may, within ten (10) days after such written notice of selection shall have been given, deliver to the Company or to Indemnitee, as the case may be, a written objection to such selection&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet the requirements of &#8220;Independent Counsel&#8221; as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;2(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Agreement, and the objection shall set forth with particularity the factual basis of such assertion.  Absent a proper and timely objection, the person so selected shall act as Independent Counsel.  If such written objection is so made and substantiated, the Independent Counsel so selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court has determined that such objection is without merit.  If, within twenty (20) days after the later of (i) submission by Indemnitee of a written request for indemnification pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;11(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereof and (ii) the final disposition of the Proceeding, no Independent Counsel shall have been selected and not objected to, either the Company or Indemnitee may petition a court of competent jurisdiction for resolution of any objection made by the Company or Indemnitee to the other&#8217;s selection of Independent Counsel and&#47;or for the appointment as Independent Counsel of a person selected by the Court or by such other person as the Court shall designate, and the person with respect to whom all objections are so resolved or the person so appointed shall act as Independent Counsel under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> hereof.  Upon the due commencement of any judicial proceeding or arbitration pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 14(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Agreement, Independent Counsel shall be discharged and relieved of any further responsibility in such capacity (subject to the applicable standards of professional conduct then prevailing).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Presumptions and Effect of Certain Proceedings.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">In making a determination with respect to entitlement to indemnification hereunder, the person, persons or entity making such determination (including, without limitation, any Independent Counsel) shall, to the fullest extent not prohibited by law, presume that Indemnitee is entitled </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">-7-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">to indemnification under this Agreement if Indemnitee has submitted an Indemnification Notice in accordance with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 11(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Agreement, and the Company shall, to the fullest extent not prohibited by law, have the burden of proof to overcome that presumption in connection with the making by any person, persons or entity of any determination contrary to that presumption.  Neither the failure of the Company (including by its directors or Independent Counsel) to have made a determination, at any time prior to the commencement of any action pursuant to this Agreement, as to whether indemnification is proper in the circumstances because Indemnitee has or has not met the applicable standard of conduct, nor an actual determination by the Company (including by its directors or Independent Counsel) that Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that Indemnitee has not met the applicable standard of conduct.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 14(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (which section allows determination regarding Indemnitee&#8217;s entitlement to indemnification under this Agreement to be deferred until following the final disposition of the Proceeding), if the person, persons or entity empowered or selected under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Agreement to determine whether Indemnitee is entitled to indemnification shall not have made a determination within sixty (60) days after receipt by the Company of the Indemnification Notice from Indemnitee therefor, the requisite determination of entitlement to indemnification shall, to the fullest extent not prohibited by law, be deemed to have been made and Indemnitee shall be entitled to such indemnification, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee&#8217;s statement not materially misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable law&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that such sixty (60)-day period may be extended for a reasonable time, not to exceed an additional thirty (30) days, if the person, persons or entity making the determination with respect to entitlement to indemnification in good faith requires such additional time for the obtaining or evaluating of documentation and&#47;or information relating thereto&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the foregoing provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall not apply (i) if the determination of entitlement to indemnification is to be made by the stockholders pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Agreement and if (A) within fifteen (15) days after receipt by the Company of the request for such determination the Board has resolved to submit such determination to the stockholders for their consideration at an annual meeting thereof to be held within seventy-five (75) days after such receipt and such determination is made thereat, or (B) a special meeting of stockholders is called within fifteen (15) days after such receipt for the purpose of making such determination, such meeting is held for such purpose within sixty (60) days after having been so called and such determination is made thereat, or (ii) if the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">nolo contendere</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or its equivalent, shall not (except as otherwise expressly provided in this Agreement) in and of itself adversely affect the right of Indemnitee to indemnification or create a presumption (i) that Indemnitee did not act in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal Proceeding, or (ii) that Indemnitee had reasonable cause to believe that his conduct was unlawful.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">For purposes of any determination of good faith, Indemnitee shall be deemed to have acted in good faith if Indemnitee&#8217;s action is based on the records or books of account of the Enterprise, including financial statements, or on information supplied to Indemnitee by the officers of the Enterprise in the course of their duties, or on the advice of legal counsel for the Enterprise, or on information or records given or reports made to the Enterprise by an independent certified public accountant or by an appraiser or other expert selected with the reasonable care by the Enterprise.  The provisions of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall not be deemed to be exclusive or to limit in any way the other circumstances in which Indemnitee may be deemed to have met the applicable standard of conduct set forth in this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The knowledge and&#47;or actions, or failure to act, of any other director, officer, Agent or employee of the Company or any other Enterprise shall not be imputed to Indemnitee for purposes of determining Indemnitee&#8217;s right to indemnification under this Agreement.</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">-8-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Remedies of Indemnitee.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 14(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (which section allows determination regarding Indemnitee&#8217;s entitlement to indemnification under this Agreement to be deferred until following the final disposition of the Proceeding), in the event that&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:75.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27pt">a determination is made pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Agreement that Indemnitee is not entitled to indemnification under this Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72.15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27pt">advancement of Expenses is not timely made pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:69.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27pt">no determination of entitlement to indemnification shall have been made pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Agreement within ninety (90) days after receipt by the Company of the Indemnification Notice, as provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 13(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:69.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27pt">payment of indemnification is not made pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, or the last sentence of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Agreement within ten (10) days after receipt by the Company of a written request therefor&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27pt">payment of indemnification pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Agreement is not made within ten (10) days after a determination has been made that Indemnitee is entitled to indemnification&#59; or </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:69.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">vi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:27pt">the Company or any other person or Enterprise takes or threatens to take any action to declare this Agreement void or unenforceable, or institutes any litigation or other action or Proceeding designed to deny, or to recover from, Indemnitee the benefits provided or intended to be provided to Indemnitee hereunder, </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">then, in any such event, Indemnitee shall be entitled to an adjudication by a court of his entitlement to such indemnification or advancement of Expenses.  Alternatively, Indemnitee, at his option, may seek an award in arbitration to be conducted by a single arbitrator pursuant to the Commercial Arbitration Rules of the American Arbitration Association.  Indemnitee shall commence such proceeding seeking an adjudication or an award in arbitration within 180 days following the date on which Indemnitee first has the right to commence such proceeding pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 14(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that the foregoing clause shall not apply in respect of a proceeding brought by Indemnitee to enforce his rights under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Agreement.  The Company shall not oppose Indemnitee&#8217;s right to seek any such adjudication or award in arbitration.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;In the event that a determination shall have been made pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Agreement that Indemnitee is not entitled to indemnification, any judicial proceeding or arbitration commenced pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be conducted in all respects as a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">de novo</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> trial or arbitration on the merits and Indemnitee shall not be prejudiced by reason of that adverse determination.  In any judicial proceeding or arbitration commenced pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the Company shall have the burden of proving Indemnitee is not entitled to indemnification or advancement of Expenses, as the case may be.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">If a determination shall have been made pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;12(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Agreement that Indemnitee is entitled to indemnification, the Company shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, absent (i)&#160;a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee&#8217;s statement not materially misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">The Company shall, to the fullest extent not prohibited by law, be precluded from asserting in any judicial proceeding or arbitration commenced pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that the procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">-9-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">in any such court or before any such arbitrator that the Company is bound by all the provisions of this Agreement.  It is the intent of the Company that, to the fullest extent permitted by law, Indemnitee not be required to incur legal fees or other Expenses associated with the interpretation, enforcement or defense of Indemnitee&#8217;s rights under this Agreement by litigation or otherwise because the cost and expense thereof would substantially detract from the benefits intended to be extended to Indemnitee hereunder.  The Company shall, to the fullest extent permitted by law, indemnify Indemnitee against any and all Expenses and, if requested by Indemnitee, shall (within ten (10) days after receipt by the Company of a written request therefor) advance, to the extent not prohibited by law, such Expenses to Indemnitee, which are incurred by Indemnitee in connection with any action brought by Indemnitee for indemnification or advance of Expenses from the Company under this Agreement or under any directors&#8217; and officers&#8217; liability insurance policies maintained by the Company, if Indemnitee is wholly successful on the underlying claims&#59; if Indemnitee is not wholly successful on the underlying claims, then such indemnification and advancement shall be only to the extent Indemnitee is successful on such underlying claims or otherwise as permitted by law, whichever is greater.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Notwithstanding anything in this Agreement to the contrary, no determination as to entitlement of Indemnitee to indemnification under this Agreement shall be required to be made prior to the final disposition of the Proceeding.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Non-exclusivity&#59; Survival of Rights&#59; Insurance&#59; Subrogation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The rights of indemnification and to advancement of Expenses as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may at any time be entitled under applicable law, the Company&#8217;s Certificate of Incorporation, the Company&#8217;s By-laws, any agreement, a vote of stockholders or a resolution of directors, or otherwise.  No amendment, alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee under this Agreement in respect of any action taken or omitted by such Indemnitee in his Corporate Status prior to such amendment, alteration or repeal.  To the extent that a change in Delaware law, whether by statute or judicial decision, permits greater indemnification or advancement of Expenses than would be afforded currently under the Company&#8217;s By-laws and this Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy by virtue of this Agreement the greater benefits so afforded by such change.  No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise.  The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">To the extent that the Company maintains any insurance policy providing liability insurance for directors, officers, employees, or Agents of the Company or any other Enterprise, Indemnitee shall be covered by such policy in accordance with its terms to the maximum extent of the coverage available for any such director, officer, employee or Agent under such policy.  If, at the time of the receipt of an Indemnification Notice pursuant to the terms hereof, the Company has director and officer liability or similar insurance (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">D&#38;O Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) in effect, the Company shall give prompt notice of such claim or of the commencement of a Proceeding, as the case may be, to the applicable insurers in accordance with the procedures set forth in the applicable policy.  The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as a result of such Proceeding in accordance with the terms of each such policy.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">In the event (i) that the Company determines to reduce materially or not to renew its D&#38;O Insurance coverage, the Company will purchase six (6) year tail coverage D&#38;O Insurance, on terms and conditions substantially similar to the existing D&#38;O Insurance (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Comparable Coverage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), for the benefit of the directors, officers, employees or Agents of the Company or any other Enterprise who had served in such capacity prior to the reduction, termination or expiration of the coverage (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Prior Directors and Officers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; or (ii) of a Change in Control, the Company will either (A) purchase six (6) year tail coverage D&#38;O Insurance with Comparable Coverage for the benefit of the directors, officers, employees or Agents of the Company or any other Enterprise who had served in such capacity prior to the closing of the transaction or the occurrence of the event constituting the Change in Control, and&#47;or (B) as </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">-10-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">applicable, secure the contractual agreement by the acquiring entity or person to purchase such coverage and require the acquiring entity or person to deliver proof of the purchase of such coverage, in form and substance satisfactory to the Company, at or prior to the closing of the transaction or the occurrence of the event constituting the Change in Control&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that this clause (ii) shall not apply if, in connection with the Change in Control, there is no material reduction or non-renewal of the existing D&#38;O Insurance coverage for the benefit of the directors, officers, employees or Agents of the Company or any other Enterprise who served in such capacity prior to the closing of the transaction or the occurrence of the event constituting the Change in Control for the six (6) year period following the date of such closing or event.  Notwithstanding the foregoing, if the annual premium for any year of such tail coverage or other continuing D&#38;O Insurance coverage would exceed 200% of the annual premium the Company paid for D&#38;O Insurance in its last full fiscal year prior to the reduction, termination or expiration of the D&#38;O Insurance or such Change in Control event, the Company (or the acquiror or successor, as the case may be) will be deemed to have satisfied its obligations under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 15(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> by purchasing as much D&#38;O Insurance for such year as can be obtained for a premium equal to 200% of such annual premium the Company paid for D&#38;O Insurance in its last full fiscal year.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">In the event of any payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such rights.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Company shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable (including Expenses for which advancement is provided hereunder) hereunder if and to the extent that Indemnitee has otherwise actually received such payment under any insurance policy, contract, agreement or otherwise.&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:25.02pt">The Company&#8217;s obligation to indemnify or to advance Expenses hereunder to Indemnitee in connection with any claim related to Indemnitee&#8217;s service as a director, officer, employee or Agent of any Enterprise other than the Company shall be reduced by any amount Indemnitee has actually received as indemnification or advancement of Expenses from such other Enterprise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Duration of Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  This Agreement shall continue in full force and effect until and terminate upon the later of&#58; (a) ten (10) years after the date that Indemnitee shall have ceased to serve as a director, officer, employee, and&#47;or Agent of the Company or any other Enterprise, and (b) one (1) year after the final termination of any Proceeding then pending in respect of which Indemnitee is granted rights of indemnification or advancement of Expenses hereunder and of any proceeding commenced by Indemnitee pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section&#160;14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Agreement relating thereto.  This Agreement shall be binding upon the Company and its successors and assigns and shall inure to the benefit of Indemnitee and his heirs, representatives, executors and administrators. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Amendments to By-laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Any amendments to the By-laws of the Company that purport to reduce or eliminate indemnification rights of Indemnitee thereunder shall have no effect with respect to this Agreement, and Indemnitee shall continue to have all of the rights and benefits of this Agreement despite any such amendments to the By-laws.  However, if the By-laws of the Company are amended to provide for greater indemnification rights or privileges, this Agreement shall not be construed so as to limit Indemnitee&#8217;s rights and privileges to the terms hereof, and Indemnitee shall be entitled to the full benefit of any such additional rights and privileges.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Severability.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  If any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever&#58; (a) the validity, legality and enforceability of the remaining provisions of this Agreement (including without limitation, each portion of any Section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest extent permitted by law&#59; (b) such provision or provisions shall be deemed reformed to the extent necessary to conform to applicable law and to give the maximum effect to the intent of the parties hereto&#59; and (c) to the fullest extent possible, the provisions of this Agreement (including, without limitation, each portion of any Section of this Agreement containing any such </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">-11-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested thereby.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Enforcement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby in order to induce Indemnitee to serve as a director, officer, employee and&#47;or Agent of the Company and&#47;or one or more other Enterprises, and the Company acknowledges that Indemnitee is relying upon this Agreement in serving as a director, officer, employee and&#47;or Agent of the Company and&#47;or any of such other Enterprises.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject matter hereof&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that this Agreement is a supplement to and in furtherance of the Certificate of Incorporation of the Company, the By-laws of the Company, any D&#38;O Insurance policy maintained by the Company and applicable law, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Modification and Waiver.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by the parties thereto.  No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions of this Agreement nor shall any waiver constitute a continuing waiver.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 21.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Notice by Indemnitee.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  Indemnitee agrees promptly to notify the Company in writing upon being served with any summons, citation, subpoena, complaint, indictment, information or other document relating to any Proceeding or matter that is or may be subject to indemnification or advancement of Expenses covered hereunder.  The failure of Indemnitee to so notify the Company shall not relieve the Company of any obligation which it may have to Indemnitee under this Agreement or otherwise. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 22.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Notices.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">All notices, requests, demands and other communications under this Agreement shall be in writing and shall be deemed to have been duly given if (a) delivered by hand and receipted for by the party to whom said notice or other communication shall have been directed, (b) mailed by certified or registered mail with postage prepaid, on the third business day after the date on which it is so mailed, (c) mailed by reputable overnight courier and receipted for by the party to whom said notice or other communication shall have been directed, or (d) sent by facsimile transmission, with receipt of oral confirmation that such transmission has been received&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If to Indemnitee&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">at the address indicated on the signature page of this Agreement, or such other address as Indemnitee shall provide to the Company in writing.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If to the Company to&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;padding-right:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Integra LifeSciences Holdings Corporation<br>1100 Campus Road<br>Princeton, New Jersey 08540<br>Attention&#58;  Chief Legal Officer </font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or to any other address as may have been furnished to Indemnitee by the Company in writing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 23.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Contribution.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  To the fullest extent permissible under applicable law, if the indemnification provided for in this Agreement is unavailable to Indemnitee for any reason whatsoever, </font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">-12-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:74.88pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by Indemnitee, whether for judgments, fines, penalties, excise taxes, amounts paid or to be paid in settlement and&#47;or Expenses, in connection with any Proceeding or other claim relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and reasonable in light of all of the circumstances of such Proceeding or other claim in order to reflect (a) the relative benefits received by the Company and Indemnitee as a result of the event(s) and&#47;or transaction(s) giving cause to such Proceeding&#59; and&#47;or (b) the relative fault of the Company (and its directors, officers, employees and Agents) and Indemnitee in connection with such event(s) and&#47;or transaction(s).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 24.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Applicable Law and Consent to Jurisdiction.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  This Agreement and the legal relations among the parties shall be governed by, and construed and enforced in accordance with, the laws of the State of Delaware, without regard to its conflict of laws rules. Except with respect to any arbitration commenced by Indemnitee pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 14(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of this Agreement, the Company and Indemnitee hereby irrevocably and unconditionally (a) agree that any action or proceeding arising out of or in connection with this Agreement shall be brought only in the Chancery Court of the State of Delaware (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Delaware Court</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and not in any other state or federal court in the United States of America or any court in any other country, (b) consent to submit to the exclusive jurisdiction of the Delaware Court for purposes of any action or proceeding arising out of or in connection with this Agreement, (c) appoint, to the extent such party is not otherwise subject to service of process in the State of Delaware, Corporation Service Company irrevocably as its agent in the State of Delaware as such party&#8217;s agent for acceptance of legal process in connection with any such action or proceeding against such party with the same legal force and validity as if served upon such party personally within the State of Delaware, (d) waive any objection to the laying of venue of any such action or proceeding in the Delaware Court, and (e) waive, and agree not to plead or to make, any claim that any such action or proceeding brought in the Delaware Court has been brought in an improper or inconvenient forum.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 25.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Construction</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">The section and subsection headings contained in this Agreement are solely for the purpose of reference and convenience, are not part of the agreement of the parties, and shall not in any way limit, modify or otherwise affect the meaning or interpretation of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">References to &#8220;Sections&#8221; or &#8220;Articles&#8221; refer to corresponding Sections or Articles of this Agreement unless otherwise specified.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Unless the context requires otherwise, the words &#8220;include,&#8221; &#8220;including&#8221; and variations thereof mean without limitation, the words &#8220;hereof,&#8221; &#8220;hereby,&#8221; &#8220;herein,&#8221; &#8220;hereunder&#8221; and similar terms refer to this Agreement as a whole and not any particular section or article in which such words appear, and any reference to a law shall include any amendment thereof or any successor thereto and any rules and regulations promulgated thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt">Unless the context requires otherwise, words in the singular include the plural, words in the plural include the singular, and words importing any gender shall be applicable to all genders.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 26.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.53pt;text-decoration:underline">Counterparts&#59; Facsimile Signatures.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  This Agreement may be executed in two or more counterparts, each of which shall for all purposes be deemed to be an original but all of which, taken together, shall constitute one and the same Agreement.  Only one such counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the existence of this Agreement.  This Agreement may be executed and delivered by facsimile or email transmission of a file in &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">.pdf</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; or similar format and upon such delivery, each signature shall be deemed to have the same effect as if the original signature had been delivered to the other party.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Signature page follows</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#93;</font></div><div style="height:79.2pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">-13-</font></div><div><font><br></font></div></div></div><div id="i4ea4fac8b94941efb9d9fa4774be829d_41"></div><hr style="page-break-after:always"><div style="min-height:98.64pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties have caused this Agreement to be signed as of the day and year first above written.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="padding-left:216pt;padding-right:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">INTEGRA LIFESCIENCES HOLDINGS CORPORATION </font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;&#160;&#160;&#160;&#160;_______________________________________</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Name&#58; </font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Title&#58; </font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">______________________________ (INDEMNITEE)</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">___________________________________________</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Printed Name&#58;</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;  </font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Address&#58;  c&#47;o Integra LifeSciences Holdings Corporation</font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">                1100 Campus Road</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;                                           Princeton, NJ  08540</font></div><div><font><br></font></div><div style="height:56.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Signature Page to Indemnification Page</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#93;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>pressreleasereneelo.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i1e2c91ee9a9f4db3bf3bb91153cec23c_38"></div><div style="min-height:72pt;width:100%"><div style="padding-right:-18pt;text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Integra LifeSciences Appoints Renee Lo as Director</font></div><div style="margin-bottom:7.5pt;margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Princeton, New Jersey, July 19, 2022 (GLOBE NEWSWIRE) -- </font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Integra LifeSciences Holdings Corporation</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;(Nasdaq&#58; IART), a leading global medical technology company, today announced the appointment of Renee Lo to its board of directors as an independent director to fill an existing vacancy, effective July 18, 2022.  </font></div><div style="margin-bottom:7.5pt;margin-top:12pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;Renee is a highly accomplished global leader in driving digital transformation across industries,&#8221; said Stuart Essig, chairman of the Integra board of directors. &#8220;Her experience and insights will be a strong complement to the board, and I look forward to partnering with Renee to  deliver shareholder value and support the company&#8217;s ongoing success.&#8221;</font></div><div style="margin-bottom:7.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ms. Lo currently serves as a general manager for Microsoft, leading its data and artificial intelligence business in Asia. She is responsible for helping strategic customers of Microsoft reshape their business models through digital technologies. Additionally, Ms. Lo chairs the </font><font style="background-color:#ffffff;color:#2f2f2f;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Women&#64;Asia</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;Microsoft Group. Prior to Microsoft, she built regional technology teams at Amazon Web Services and ran the global business development team for Amazon.com, focusing on telecommunications, consumer hardware devices, and new services. Ms. Lo has more than 13 years of experience in North America, including roles with SAP and Pivotal Software, in addition to Amazon, focusing on collaborative and cloud technologies. She has held leadership roles within product development, commercial, operations, business and corporate strategy. </font></div><div style="margin-bottom:7.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ms. Lo received a bachelor&#8217;s degree in computer science from the University of British Columbia, and an M.B.A. from the University of Manchester. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">About Integra LifeSciences<br></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Integra LifeSciences is a global leader in regenerative tissue technologies and neurosurgical solutions dedicated to limiting uncertainty for clinicians so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, Aurora</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, Bactiseal</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;BioD, CerebroFlo</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, CereLink</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;Certas</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;Plus, Codman</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, CUSA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, Cytal</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, DuraGen</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, DuraSeal</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, Gentrix</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, ICP Express</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, Integra</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, Licox</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;, MAYFIELD</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, MediHoney</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, MicroFrance</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, MicroMatrix</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, NeuraGen</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, NeuraWrap</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">&#8482;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, PriMatrix</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, SurgiMend</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, TCC-EZ</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;and VersaTru</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. For the latest news and information about Integra and its products, please visit&#160;</font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">www.integralife.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div><font><br></font></div><div style="margin-bottom:7.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties and reflect the Company's judgment as of the date of this release.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ from predicted results. These risks and uncertainties include market conditions and other factors beyond the Company's control and the economic, competitive, governmental, technological and other factors identified under the heading &#34;Risk Factors&#34; included in item 1A of Integra's Annual Report on Form 10-K for the year ended December 31, 2021, and information contained in subsequent filings with the Securities and Exchange Commission. These forward-looking statements are made only as the date thereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.</font></div><div style="margin-bottom:7.5pt"><font><br></font></div><div style="margin-bottom:7.5pt;margin-top:7.5pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Contacts&#58;</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Investors&#58;</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Chris Ward<br>(609) 936-2322 </font></div><div><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">chris.ward&#64;integralife.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Media&#58;</font></div><div style="margin-bottom:7.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Laurene Isip<br>(609) 208-8121<br></font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">laurene.isip&#64;integralife.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>iart-20220718.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:cbb5b175-68b1-4695-907f-f3ae3e40a02f,g:71eabf76-08c3-4a66-896a-3d8217fba004-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iart="http://integralife.com/20220718" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://integralife.com/20220718">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iart-20220718_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iart-20220718_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iart-20220718_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformation" roleURI="http://integralife.com/role/DocumentandEntityInformation">
        <link:definition>0001001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>iart-20220718_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:cbb5b175-68b1-4695-907f-f3ae3e40a02f,g:71eabf76-08c3-4a66-896a-3d8217fba004-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://integralife.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="iart-20220718.xsd#DocumentandEntityInformation"/>
  <link:definitionLink xlink:role="http://integralife.com/role/DocumentandEntityInformation" xlink:type="extended" id="i46b9fa2199e14750b4ee573e725d7e35_DocumentandEntityInformation">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_4152e303-ec7a-4aa0-b7fe-24c0404de229" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_DocumentType_4152e303-ec7a-4aa0-b7fe-24c0404de229" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8bc9de4a-dd87-46f1-bd69-5668a68deaa7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_DocumentPeriodEndDate_8bc9de4a-dd87-46f1-bd69-5668a68deaa7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_c2673d18-48a3-4221-9a6c-e28ead44ede1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_EntityRegistrantName_c2673d18-48a3-4221-9a6c-e28ead44ede1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_828a1973-ea24-4eb5-ab8a-a5e6df6414dc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_EntityIncorporationStateCountryCode_828a1973-ea24-4eb5-ab8a-a5e6df6414dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_28a099fa-b1e1-4648-9f77-0861b1ad17cb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_EntityFileNumber_28a099fa-b1e1-4648-9f77-0861b1ad17cb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_27ec4c17-f6f4-4a94-8caf-9339a39827c4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_EntityTaxIdentificationNumber_27ec4c17-f6f4-4a94-8caf-9339a39827c4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_b127e4b2-ec70-416e-9a42-223d91b440bb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_EntityAddressAddressLine1_b127e4b2-ec70-416e-9a42-223d91b440bb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_e512fc23-1f2b-4290-b33d-eeccb6652c5d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_EntityAddressCityOrTown_e512fc23-1f2b-4290-b33d-eeccb6652c5d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_89b9342c-96b0-4419-80e2-3910024d4e58" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_EntityAddressStateOrProvince_89b9342c-96b0-4419-80e2-3910024d4e58" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_47104b48-93cb-427b-9571-93a3208bcc64" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_EntityAddressPostalZipCode_47104b48-93cb-427b-9571-93a3208bcc64" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_4cffec1e-12d4-4ed9-88d0-fdca08a374c0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_CityAreaCode_4cffec1e-12d4-4ed9-88d0-fdca08a374c0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_70d0309b-3bd7-495a-96e1-84757f731f82" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_LocalPhoneNumber_70d0309b-3bd7-495a-96e1-84757f731f82" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_1f2d41aa-b56d-4745-8f81-11c2a4cb8d02" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_WrittenCommunications_1f2d41aa-b56d-4745-8f81-11c2a4cb8d02" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_a192077c-9557-431a-8d5d-e4f8901f93ea" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_SolicitingMaterial_a192077c-9557-431a-8d5d-e4f8901f93ea" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_f35f1603-d33d-496f-a6e0-4f9df9452520" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_PreCommencementTenderOffer_f35f1603-d33d-496f-a6e0-4f9df9452520" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_654b9ba9-f8ae-4f85-ab78-a44f7e16f27c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_654b9ba9-f8ae-4f85-ab78-a44f7e16f27c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_be462c17-cebd-400a-b5f4-e690f653c07f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_Security12bTitle_be462c17-cebd-400a-b5f4-e690f653c07f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_3e82cbc5-b05b-47d4-aa96-6df65caa11e3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_TradingSymbol_3e82cbc5-b05b-47d4-aa96-6df65caa11e3" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c7d0d866-0db6-4ddf-ad81-362d875d8a67" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_SecurityExchangeName_c7d0d866-0db6-4ddf-ad81-362d875d8a67" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3bebae34-5592-4ad6-8b68-3219462a2c38" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_EntityEmergingGrowthCompany_3bebae34-5592-4ad6-8b68-3219462a2c38" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_c1a1ea00-50a7-4c5f-b9b3-0d7a1ae1ec4a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_EntityCentralIndexKey_c1a1ea00-50a7-4c5f-b9b3-0d7a1ae1ec4a" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_163cbe90-3cc2-4da7-84e4-f05917bdcf8b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_AmendmentFlag_163cbe90-3cc2-4da7-84e4-f05917bdcf8b" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_cceb24eb-e7eb-43f7-8bd1-5c4c4b594a69" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_EntitiesTable_cceb24eb-e7eb-43f7-8bd1-5c4c4b594a69" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_55898311-1d4d-498c-819e-942ffce813fc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_cceb24eb-e7eb-43f7-8bd1-5c4c4b594a69" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_55898311-1d4d-498c-819e-942ffce813fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_55898311-1d4d-498c-819e-942ffce813fc_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_55898311-1d4d-498c-819e-942ffce813fc" xlink:to="loc_dei_AddressTypeDomain_55898311-1d4d-498c-819e-942ffce813fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_d7bdf6da-5ccd-4bf4-ad2d-3134f9fb74fa" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_55898311-1d4d-498c-819e-942ffce813fc" xlink:to="loc_dei_AddressTypeDomain_d7bdf6da-5ccd-4bf4-ad2d-3134f9fb74fa" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>iart-20220718_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:cbb5b175-68b1-4695-907f-f3ae3e40a02f,g:71eabf76-08c3-4a66-896a-3d8217fba004-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityAddressStateOrProvince_dfc28ce6-5c25-4b18-8008-48da55cf0156_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_25b7e13f-cb09-4b55-9b6c-d0a564009fee_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_73d05c54-2e54-46e8-8b4e-f8b7e98b707f_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c59d9439-0d6b-4020-b4b1-da9749a5c5b9_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_f052484e-ccea-42f2-90d6-6ce542c003fb_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_0a14703e-56e5-44a9-b9ae-3c19b5763659_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_04ce8f01-8ba1-4e35-b727-07358f5609fd_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AddressTypeDomain_163e8bfd-c732-483f-bc7a-3a7420792766_terseLabel_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:label id="lab_dei_AddressTypeDomain_label_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AddressTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain" xlink:to="lab_dei_AddressTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_313c46f1-bd8f-40e1-b1e3-a2a863d3eeb2_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_8d65a082-ad4d-4215-bf8c-057324d22c31_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_d3976b90-aae6-4406-a5ea-cef8bcaed374_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_853c8c36-f21f-4f0b-953f-efd5ff43327f_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_0dcc9a0d-5595-4ed9-b740-30805f30b028_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_245ec3b2-8ad4-4c0a-b6b8-8e09b9d0db0e_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_507dd067-5746-433b-b034-1b40e68cd2d5_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_ce92ea10-cfca-4702-b7e9-bfebecd54831_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_ada9ccf6-0375-4064-9019-ba8a4f08b853_terseLabel_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_label_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis" xlink:to="lab_dei_EntityAddressesAddressTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_4f2bf423-459c-4304-aee7-b54541bc853b_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_76aea1c9-5053-453b-9c5d-755ac2c7bcec_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_8df3c923-86b1-4fe6-ab8f-76f06345cba0_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_8f37e397-8e0f-48ac-af8f-cdb8c443fd7b_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_394f0502-9623-4bc3-a05d-e78794212c16_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_1371f873-9f07-4d2b-a608-8a06047b8093_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_c184f0df-74e2-4f48-8899-13c4facc58e8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_a21b654d-9a90-471d-b44b-4f7bb90fca41_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_53dc8cca-12e8-4e29-9123-b007e64068ec_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_f04ddeaf-ed0a-4cd3-b837-0fa790c99bcd_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>iart-20220718_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:cbb5b175-68b1-4695-907f-f3ae3e40a02f,g:71eabf76-08c3-4a66-896a-3d8217fba004-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://integralife.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="iart-20220718.xsd#DocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://integralife.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_69fc2946-ae86-45e2-a9b5-e0ac4e27154e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_cceb24eb-e7eb-43f7-8bd1-5c4c4b594a69" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_69fc2946-ae86-45e2-a9b5-e0ac4e27154e" xlink:to="loc_dei_EntitiesTable_cceb24eb-e7eb-43f7-8bd1-5c4c4b594a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_55898311-1d4d-498c-819e-942ffce813fc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_cceb24eb-e7eb-43f7-8bd1-5c4c4b594a69" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_55898311-1d4d-498c-819e-942ffce813fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_d7bdf6da-5ccd-4bf4-ad2d-3134f9fb74fa" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AddressTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_55898311-1d4d-498c-819e-942ffce813fc" xlink:to="loc_dei_AddressTypeDomain_d7bdf6da-5ccd-4bf4-ad2d-3134f9fb74fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_cceb24eb-e7eb-43f7-8bd1-5c4c4b594a69" xlink:to="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_4152e303-ec7a-4aa0-b7fe-24c0404de229" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_DocumentType_4152e303-ec7a-4aa0-b7fe-24c0404de229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8bc9de4a-dd87-46f1-bd69-5668a68deaa7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_DocumentPeriodEndDate_8bc9de4a-dd87-46f1-bd69-5668a68deaa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_c2673d18-48a3-4221-9a6c-e28ead44ede1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_EntityRegistrantName_c2673d18-48a3-4221-9a6c-e28ead44ede1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_828a1973-ea24-4eb5-ab8a-a5e6df6414dc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_EntityIncorporationStateCountryCode_828a1973-ea24-4eb5-ab8a-a5e6df6414dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_28a099fa-b1e1-4648-9f77-0861b1ad17cb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_EntityFileNumber_28a099fa-b1e1-4648-9f77-0861b1ad17cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_27ec4c17-f6f4-4a94-8caf-9339a39827c4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_EntityTaxIdentificationNumber_27ec4c17-f6f4-4a94-8caf-9339a39827c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_b127e4b2-ec70-416e-9a42-223d91b440bb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_EntityAddressAddressLine1_b127e4b2-ec70-416e-9a42-223d91b440bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_e512fc23-1f2b-4290-b33d-eeccb6652c5d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_EntityAddressCityOrTown_e512fc23-1f2b-4290-b33d-eeccb6652c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_89b9342c-96b0-4419-80e2-3910024d4e58" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_EntityAddressStateOrProvince_89b9342c-96b0-4419-80e2-3910024d4e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_47104b48-93cb-427b-9571-93a3208bcc64" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_EntityAddressPostalZipCode_47104b48-93cb-427b-9571-93a3208bcc64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_4cffec1e-12d4-4ed9-88d0-fdca08a374c0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_CityAreaCode_4cffec1e-12d4-4ed9-88d0-fdca08a374c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_70d0309b-3bd7-495a-96e1-84757f731f82" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_LocalPhoneNumber_70d0309b-3bd7-495a-96e1-84757f731f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_1f2d41aa-b56d-4745-8f81-11c2a4cb8d02" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_WrittenCommunications_1f2d41aa-b56d-4745-8f81-11c2a4cb8d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_a192077c-9557-431a-8d5d-e4f8901f93ea" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_SolicitingMaterial_a192077c-9557-431a-8d5d-e4f8901f93ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_f35f1603-d33d-496f-a6e0-4f9df9452520" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_PreCommencementTenderOffer_f35f1603-d33d-496f-a6e0-4f9df9452520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_654b9ba9-f8ae-4f85-ab78-a44f7e16f27c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_654b9ba9-f8ae-4f85-ab78-a44f7e16f27c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_be462c17-cebd-400a-b5f4-e690f653c07f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_Security12bTitle_be462c17-cebd-400a-b5f4-e690f653c07f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_3e82cbc5-b05b-47d4-aa96-6df65caa11e3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_TradingSymbol_3e82cbc5-b05b-47d4-aa96-6df65caa11e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c7d0d866-0db6-4ddf-ad81-362d875d8a67" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_SecurityExchangeName_c7d0d866-0db6-4ddf-ad81-362d875d8a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3bebae34-5592-4ad6-8b68-3219462a2c38" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_EntityEmergingGrowthCompany_3bebae34-5592-4ad6-8b68-3219462a2c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_c1a1ea00-50a7-4c5f-b9b3-0d7a1ae1ec4a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_EntityCentralIndexKey_c1a1ea00-50a7-4c5f-b9b3-0d7a1ae1ec4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_163cbe90-3cc2-4da7-84e4-f05917bdcf8b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_a88f4450-2df0-42f3-9939-74e327f142f4" xlink:to="loc_dei_AmendmentFlag_163cbe90-3cc2-4da7-84e4-f05917bdcf8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140577961578688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jul. 18, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 18,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">INTEGRA LIFESCIENCES HOLDINGS CORP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-26224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">51-0317849<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1100 Campus Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Princeton<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08540<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">609<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">275-0500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, Par Value $.01 Per Share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IART<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000917520<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>iart-20220718_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="iart-20220718.xsd" xlink:type="simple"/>
    <context id="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000917520</identifier>
        </entity>
        <period>
            <startDate>2022-07-18</startDate>
            <endDate>2022-07-18</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718"
      id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF80L2ZyYWc6NmQ5ZjIyNjlmZTg3NDllNmJlNzA3NDc3ZDNmOGJkMTEvdGFibGU6ZmRkYzIzZTJiZTJjNDkwNDkzMjNlZDY0MWQxOTAxNmQvdGFibGVyYW5nZTpmZGRjMjNlMmJlMmM0OTA0OTMyM2VkNjQxZDE5MDE2ZF8yLTEtMS0xLTExNTI2Nw_6ca8d71f-0b09-453e-8d25-becac67fb64b">0000917520</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718"
      id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF80L2ZyYWc6NmQ5ZjIyNjlmZTg3NDllNmJlNzA3NDc3ZDNmOGJkMTEvdGFibGU6ZmRkYzIzZTJiZTJjNDkwNDkzMjNlZDY0MWQxOTAxNmQvdGFibGVyYW5nZTpmZGRjMjNlMmJlMmM0OTA0OTMyM2VkNjQxZDE5MDE2ZF81LTEtMS0xLTExNTI2Nw_db69a86f-070b-457e-b264-8378c27858be">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718"
      id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8xNzQy_4da1b1c6-195c-4fdb-9f14-80be2fa9f16a">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718"
      id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8yMzM_b0a6fe15-deb8-44fe-8e1f-9424d2e4d4aa">2022-07-18</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718"
      id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8xNzM1_d49c437d-07cb-4f80-8bcb-cf3e8feee66f">INTEGRA LIFESCIENCES HOLDINGS CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718"
      id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGFibGU6MDMzMjZiOWQyYzZlNGMwZjk2YWZmMTE2YjU1YmJjZDEvdGFibGVyYW5nZTowMzMyNmI5ZDJjNmU0YzBmOTZhZmYxMTZiNTViYmNkMV8wLTAtMS0xLTExNTI2Nw_bd0252cf-00b2-4701-8d07-9b9e8862ac5e">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718"
      id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGFibGU6MDMzMjZiOWQyYzZlNGMwZjk2YWZmMTE2YjU1YmJjZDEvdGFibGVyYW5nZTowMzMyNmI5ZDJjNmU0YzBmOTZhZmYxMTZiNTViYmNkMV8wLTEtMS0xLTExNTI2Nw_59a97d02-2a35-452d-a6ab-b4b88d086694">0-26224</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718"
      id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGFibGU6MDMzMjZiOWQyYzZlNGMwZjk2YWZmMTE2YjU1YmJjZDEvdGFibGVyYW5nZTowMzMyNmI5ZDJjNmU0YzBmOTZhZmYxMTZiNTViYmNkMV8wLTItMS0xLTExNTI2Nw_79d12c06-f5f5-48c5-b8d0-b0fc9bde8f6a">51-0317849</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718"
      id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8xNzM2_7f83a22e-bd79-489f-9ae0-b1dca13516ba">1100 Campus Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718"
      id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8xNzM3_da1efb9d-6fc7-4f06-8844-afe6cc63ea28">Princeton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718"
      id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8xNzM4_e3041664-a8d8-4cb5-badd-c944a2c6d512">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718"
      id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8xNzQz_4a9fdcf0-6742-4dea-af58-d48b86605aa9">08540</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718"
      id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8xNzM5_35b04fe6-51bb-4035-aac7-7e16e73e929c">609</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718"
      id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8xNzQ0_8473a5bc-891b-4d4a-8c03-223ccc2d0be7">275-0500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718"
      id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8xNzQ1_a59fbb9e-473e-484b-967f-ebde86be278f">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718"
      id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8xNzQw_10cbb97d-a537-4234-b5d1-d9653f57bf04">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718"
      id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8xNzQ2_8007c07a-e25a-43e8-a850-5641464baa12">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718"
      id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8xNzQx_f44ce828-4a91-475e-8534-b01b7642d7f6">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718"
      id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGFibGU6MzBjM2MyYmZjOTJkNDdjNmI5Zjc4M2ZkN2Y2ZmY4ZTkvdGFibGVyYW5nZTozMGMzYzJiZmM5MmQ0N2M2YjlmNzgzZmQ3ZjZmZjhlOV8xLTAtMS0xLTExNTI2Nw_3154d3e0-bf29-4c6c-bcef-e9c97478257b">Common Stock, Par Value $.01 Per Share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718"
      id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGFibGU6MzBjM2MyYmZjOTJkNDdjNmI5Zjc4M2ZkN2Y2ZmY4ZTkvdGFibGVyYW5nZTozMGMzYzJiZmM5MmQ0N2M2YjlmNzgzZmQ3ZjZmZjhlOV8xLTEtMS0xLTExNTI2Nw_fce9638b-8598-4992-bd18-013f35c8a50f">IART</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718"
      id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGFibGU6MzBjM2MyYmZjOTJkNDdjNmI5Zjc4M2ZkN2Y2ZmY4ZTkvdGFibGVyYW5nZTozMGMzYzJiZmM5MmQ0N2M2YjlmNzgzZmQ3ZjZmZjhlOV8xLTItMS0xLTExNTI2Nw_af34c435-1146-4553-b627-c4a98b8d3739">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718"
      id="id3VybDovL2RvY3MudjEvZG9jOmU3MjAwYzljNzBhOTQyYjhiMWNkNjE3MDQxZjUxMDAwL3NlYzplNzIwMGM5YzcwYTk0MmI4YjFjZDYxNzA0MWY1MTAwMF8xL2ZyYWc6ZWExMGZiM2JjM2U2NDYwZThjZjVjYjg2NDQ0Y2I4MGQvdGV4dHJlZ2lvbjplYTEwZmIzYmMzZTY0NjBlOGNmNWNiODY0NDRjYjgwZF8xNzQ3_2bdc1e12-48d0-444e-b964-5e8093172582">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M;;4[&^\J1F;%>70A#9QNB^*:,[ +VP">+Z4T;Q5[Q"U_H1C\!U!+ P04
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MJ'7N0;#W\!J-'<V/'[?\ 5!+ P04    " "-@O-4)!Z;HJT   #X 0  &@
M 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I0P5,
M75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LIDR^SO
M *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\./VR
M./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/
M3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ C8+S5&60>9(9 0  SP,
M !,   !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +
M77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5
M!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP
M39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J>SM
M2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q32:>
M,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/]
M#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4
M" "-@O-4!T%-8H$   "Q    $               @ $     9&]C4')O<',O
M87!P+GAM;%!+ 0(4 Q0    ( (V"\U3^.WL2[@   "L"   1
M  "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( (V"\U297)PC
M$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL
M4$L! A0#%     @ C8+S5(*9S"U=!   K1   !@              ("!#0@
M 'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( (V"\U2?H!OP
ML0(  .(,   -              "  : ,  !X;"]S='EL97,N>&UL4$L! A0#
M%     @ C8+S5)>*NQS     $P(   L              ( !? \  %]R96QS
M+RYR96QS4$L! A0#%     @ C8+S5!PX9>H_ 0  / (   \
M ( !91   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( (V"\U0D'INBK0
M /@!   :              "  =$1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN
M<F5L<U!+ 0(4 Q0    ( (V"\U1ED'F2&0$  ,\#   3              "
M ;82  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(    4
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="iart-20220718.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://integralife.com/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="iart-20220718.htm">iart-20220718.htm</File>
    <File>ex101indemnificationagreem.htm</File>
    <File>iart-20220718.xsd</File>
    <File>iart-20220718_def.xml</File>
    <File>iart-20220718_lab.xml</File>
    <File>iart-20220718_pre.xml</File>
    <File>pressreleasereneelo.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "iart-20220718.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "iart-20220718_def.xml"
     ]
    },
    "inline": {
     "local": [
      "iart-20220718.htm"
     ]
    },
    "labelLink": {
     "local": [
      "iart-20220718_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "iart-20220718_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "iart-20220718.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd"
     ]
    }
   },
   "elementCount": 27,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "iart",
   "nsuri": "http://integralife.com/20220718",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20220718.htm",
      "contextRef": "i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Document and Entity Information",
     "role": "http://integralife.com/role/DocumentandEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "iart-20220718.htm",
      "contextRef": "i0760678f861645b3a42c0b8676d9c32e_D20220718-20220718",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]",
        "terseLabel": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]",
        "terseLabel": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://integralife.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0000917520-22-000029-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000917520-22-000029-xbrl.zip
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MDT-IV,3V1IP<8]VIQ L<V%2U"[BX<E__X"]E)A+\"Y8,AJ"R_4R<Z:-,A=N
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MR'C"9E0>-3")J$2<O)^*Q">%F\_U1#>=/*'$ZG>>U].F62-/FCI3''9:GQ;
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M8OGBDX7T?&.EZ"(CV&()O2>CIP>7)&D\B]TP**VV<B<=YJ6,FY'Q=IR% 0B
MAKK6J9IQAU=3*H:%5>P84.X40=9I7A(]CQF3MWG6>2CEW/O>SF'Y&\!2P'<Q
M+Y2F>WS-*[6"-LF+3+6180>ZD-<-5L9H8_\"S&1\9TDXM%4)-Y\]<8;Z&3HC
M3/W2/= H^#G88B&!$WP5W]6^9%7'UPQR);"6:PGG6T( DG&+-Z1+ET9KP!.Z
M-S=?QH_6MY?V8,,/K,U:Z/_Q,\K_[:>3IX]^AJW>YGDP)+01S0^:D0*^@.\4
M>>K&*7DLVAH-CD<PX&"0\$643KCR'6..6P_;723'MT 'TAW5\3)LB(4FDFP-
M7X%BB68Q3EQCHY1&L33%TQ)3.9FM?1,0[)!+CYU;S] ^M1$,?CV9RGMX76TK
M@3H1^^BDE#N[D=M]N$T0T*GPA<'8N._WGO=1KU*R<^NDG/XIYC?<G&61]3N>
M(C>D;[D_:^78=2J-&!.M^A?+<18H34@'.GEA*TO6)B.@K@E,)"!B8*)"_'=X
M:UC2>@[J^C7ZH#U<#Q\\"TT^HX-$+OQ=Z%^4DT69?%06K^UKHC$G[_::G?>.
M>S*>AD^>%6@EBJ4-!!"NBL>:!C<*KGY6P&FSH]1O/8@0JRJ.11=*50+/(\_
MDK@)F*[G0H8B<H>X9MBA.SV8;==U[NEK,-JX><VLH$IX+=.\ 'M-1INQ(W4:
M49G/8.KJ*.66,)O<9.&0H'Y24@^9=%CQK>!Y4&K,W4(G?O<$1%R?F JB/4+
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M>8A,Q&X(PZI2]"V\,Y*%LQ\8@&*Q!YSME&\;LW//SD"A9KKD!!-^@O7H,H?
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M$*X%K*C@X61528F,5'.O'5V@J,%+.@8-&JMEMX.$6S'Z1CSN:+=<<'(VN@'
MX3JU;$!<8&&O<SP8*X&B6.Y6ZH!&]4\E%<Y..5,?&.)M+$D$!X@L2BW)K7Z^
MJH%*IDP/H_E50JN,=#\Q$G-<\#B_ 7G< 9Y0NU1ZDC$P@[):<-H%V DH>7/!
MLU*P>,I.XM;+"_EG1M/DZ V0?CA?P"KBR'3TV@\W%XS1X\(Q5&B=XT;=EO5D
MH2U&J9D1\=%1PY80RML]<OJHY:WD17Q+@>3$,H1O.57U_.8$H;O K+' FAMR
M#*<\9S@,\BDOAO)^0ZK4R>8$[^6+-O_@'LR2=&PT$V!B_TF(2F>1MK^,OT0!
M8XRJV$!SV* X:^QS;[EKK'=[92"BLRV6DJZ,%L9@-8WKIHN''F9J2JU4?'6N
MP;R0I'G,M,3^K<.,.V$!I/KX45G6=+9A*R&& [>LMM-'AI]'[N1+FS2E*[E5
MV,!J#<?V$F=?2S2!I"ZA0W9A%>;P78WBZ[U[D_AW/H:AQ )# YY?HE%=PR-J
M><GU8M^\S)V:I7;!GA8M?4^PO..$OI<B'H8%5GZ<\R3ZTC11L9?;,]^ZS%,%
M.L9P/(I%84*PJ6+"2'&=^70AQ;T9C(VJRG(G-@@&K].LC3%T^O*H-4PP7_Y,
M(>G7XZXV%642HOM3?+M^WCUL_+O!QM\9:: 6)'$S13>5XD[A*Y*_G,.[CR'N
M,7\A8>)NQ@*CGYP1>^8"1&0D7^D!Q@FPS_$S('RB:ON^O/'Q#>#X)^\Y9<_@
M K!/ANVO=,=UX=]O('0NS9OG%E 5FC?O_9H25OQ[=H4*+6%\)9T">-I[>T<[
M-Q(R@-9].)KK^ZW.^GY+-LM=DQW,08P#5F[;JA-S>3C$6-D(@EGL4(AK_+[1
MQ.AOLF13)8UP'.0'\<. DZVB0APJ*F08K8O) 6KS-0PLM*]"UF50L6;;FM%2
MS.-B$*[-=3$+(=G266V2)P@.K%.AC?PN,.U[MD]/C6YXJE@VM$%'9+.:QVRQ
M")!U36ONC7$_R;_T/F>^S!(FGUY0/EWZJF?*X3N9>&.<A"N4/[%OI!BG.T79
M=H$9!'!^0)?(!.+?+;SJO8'/?'>LXMU2MH+9=?'XU4UN^Q9CYY&$&\#RD[$T
M4K#.DY@XS^%! E%64;_J&3&B3<!@2,F'KA'*.-8JGU&9+.QB]+&+TN25*59O
M/,D@>(LY./R$S%VPBR6X4E/MX7C=I $(1==BY"#,'L6M&82[I2FX%3DS,-*T
M3IVPTC<$] U3N^?@WKK'^#@>'K)!X=&X3(0C>J Z&H<SU6R>?DSZ\(Z(U^-E
M,AU!LM =>,C(=LX3V\2-;/M*9+D!M0W!6:W823,_)X2HY=@(=7,1'.3#>$O[
M=B7%(YTE*(9?JJ*W"D#XVT\O3D8F<N]]0")/.=CR+*L7CX>1??>0EA:DY?$7
M0EKP873RWP_TF8K.0'4^G[PX>W%VHJ:3%\F+:73V[-G91#T_?9'\Z^SDP=?C
M8%X\/WYZUH.#Z=E0PF-^]_U\-B!\_;S4&_-5?V-<SY KN5XZ=\I+O7H3_'7U
MX<WE^_?!7W]<OKM\^WOHM[H3*2V"0MHCT\6]$"<ELA5L:BP @T5TLE-=@+,2
M37*XBK37=VW'EMS(P1?H^\PG3SMHY2,.LK9R1J[>?+C\^[OSX/75[Y?O+ZXN
MWUQ<O@_^>/OZU=6;O[\/+MZ^^_/MN_,/5V_?W.GY!C%MZT5].U?ZT9+RVXJ@
MVT-:Z%^;_6\G'WWHF=^ .\EX]KUZK ](ZWGGY_I" ?^ZK_UHO;->N(.#JS>O
M+O_QYNK#Y>7AR-3%[BJ>#37+SFH7[)S!9(+5)COY%$/*)-A-W7C.?3S2K10S
MM#;8O$MJ%Y\Y:/VOT^8U#I?UKO'17?_9WH8U_W.;WOXGD&ZWC<.Q;DKAR5/N
MU/@N.84?ES=XM.U,E%W %V>B_L1,5-/]9-NG\/??><UWS4QY_YSDR0K^-:\6
MZ:__'U!+ P04    " "-@O-4PCG3?6,6  !<B   $0   &EA<G0M,C R,C W
M,3@N:'1M[5U9=]K(MG[O7U&7OO<<9RT7:!YPXK,(8#=I PZ0N.'%JR25C+ &
MCB0,^-??724)8XQC)_&8N%<G 53CKF^/M:OT_C^+P$<7-$Z\*/Q0$LM""?UG
M__W_8/S/Q]X1:D3V+*!ABNHQ)2EUT-Q+Q^C$H<DY<N,H0"=1?.Y=$(QYG7HT
M7<;>V3A%DB!)&P_CJFU9JB7J*M8,2\2*9JK8%'07NS*A,E4$(DCN[EE5%RFQ
M7%W#@F'+6"&:A@U3(UAV#$G478L(@K+K5*DN"8)MVKI 3$6RH$G;T41=4$17
M%05!8-V.4Y@=S#!,JKX7GG\HC=-T6JU4YO-Y>6'%?CF*SRK0C%QACRV2T%)>
M?'&C_%SFI473-"O\Z:IHXFTK",V*E7_:1WU[3 ."O3!)26BO.O 6MXU&E"M>
M"!U0M@1Y\=M'PJ98M.G0JY'P!A-JE\^BBPH\@(8E\:KS='OO5QU7TIB$B1O%
M 4D!&ZRZ@ 4)B]):(Q@ZN-90T>&WVA%56%DLKP;#.O>^L337*%?U27CVH41#
M_*5?@@6FQ-E_']"4(%8?T__.O(L/I7H4I@!;/%A.H9J=??M02NDBK7""5?;_
M^../]ZF7^G3?(W&*&6 %733>5[(?WU>RIJW(6>Z_=[P+E*1+GWXH.5XR]<FR
M&D8AA0%XBRHK2./LH^<X-.0?X7D'>"?V[*S_1=JC[H>2)^B:H.F&:VBBIJB6
M3!3)%BQ#TS7'M&6)GC:*H:S&5$(A"5C7U*LV0QC?L@[3B8G?"AVZ^)LN2\AS
MH&E'_KJT&M'%D=2[&,KMF3-I7HP.S4DW^"*W)[7Y\-*?="X_CKN#S\OA9.RU
M3SKGG4E3;C<^+T:3+XMVHS8_DCO^\'+J=RY;\_9A6QU>VO/AX%QH!RUE.#F8
MC!K#1>>R)K1/AF)[4)NW#PSA2!HMAR>VU@D^JZ-):]F9^,%H<"9W&K[?"3Y!
M6S7X;,NC1B?H'GXZ;P^:%\[A@6<=?M%&0>]\>-FZ' T^>?!GTFF<S^'/97O2
M\:$OZ.?SHCNH+:#MO,Y7Z$L-1X-I,#KL35BY-O31#MH"E(,_[65;^@KS@CDU
MFFJ[T91&!\;R:-!,VWUA ?\N.H.6U)F?:C8Q'%UTL6 ))E94F6+#D51L49O8
M&@@:3;%*^R!)!!.$EB2\KUQ;UL=<Y1H(78<)W@.?G+VM[EVK*VY97<?23&)H
ML+JZ8,'JZA1;DJ9@0]8-6](-U;" ?UWB)_3&PE:NLW),71I3D$#)%@G$-$$U
MX3(>EAYQS5!-0>Y\*"5>,/69V.*_C6..C'5A4UXD#C11N=Y&UO]5I_D8DF@6
M\V]<7E9SN&78^!&X%0U1+E&*;Y[#OKL>C1$?$-TJWNNMOZ]SQF;E_>*GZZU/
M@;Z14WP#L1ZG#; K]MF@8*$PD[^;SU;#=&XI6CPIOA>=5*X1JJ#JBHR5-=%=
M 0&?27E.SKM,BU.QM%XGUPR!%^(Q9>9/5=:FZ=[<<])Q%<K_7XF7VW^?3 D@
MRHHK4#O[G#5RHRDV8$Q\[RRLVD!!&I>RRL5S._*CN/JGP/_;<V&&V"6!YR^K
M_QYX >"T0^>H%P4D_/=N NH7]'3LN5G!Q+ND5=&  ?*O\VS$.K3#5'8Q U%B
MP_[2:0V:#=0?U ;-/KH^Z!<XW'ZS_J77&K1@K+5. S7_J?]5ZQPV4;W;;K?Z
M_5:W<Z\Y3&8)H'A9NGW!GG3N<EG=F+VR=?8G)!E[X5D:A;NH4:Z7P0A7%?,U
MSOA^JWW0[;71(RKAPOG)C,CGU,&+0@>/3IJ+]N'(:TN?)FWIB]1I#.>CP7@R
MFGR=#"=G\/VS,)1:2ON0Z=.OBO/7)W\D^1?69.H/!\WY*&A=#H,VZ..AT)E\
M]+N'G:!STO&ZH(L[C1YK8P[Z%/K_O#Q5'"*"Y-.P:*HV5ES'PJ8K@@85+"JY
M!#YKI+1OX+\W]>=KA)QP+\B!>.DU.P/4:QYW>X/G%(B;X]TN$HYG<3(CX+^G
M$>I3FSE@2)11%"-1W7'>H<A]^7-(QY2-?19[J0>M-A?V& PPBFIVRL8OFK+R
M*P!N^^298<-FV:/3*$[13O&=$C!M:)(B>L'",S%_3)UWU:<0B,?<P&IF9E<)
M9;X]-+](JP[\@@/H<\RJ88<L\1+&BFGX>TG09?NR?6H)1'.IJ&*'6@96%!<<
M3 K^)MB4BB-1Q5$("-!/,W^)1&.7Q\Q^!5&JW4N4/GJ,I$?/O(0%G](.//F]
MX ?]M\531S%M1=8=<)=L<(%=0\"&!9]L5Z:&2RG5-+>TW^H,FH>]&CIJ'33[
M]5:S4P?S^:_N4:/5.>R#Z=P[W@1EMU<;W->6?E;IN=-<$- 2#!F9$"T0@4B"
MDBFUF:_J("]$7IH@T"L@0^-WWS^O.U@N(/$9^(9I-*TR2WY;*RFQ?%J4MZ(8
MO%(,5/+)-*'5XL->$7O,HJN85]K+6[>B-(T"WL$%C5//)G[>">\O>YS[I+I4
M%B29,6$*SF_J%!WG'FN9\V<E=6X^4X2R(*JW/A;*XJW/OM6LI)5-TWSX9LVR
M9FCW:K;"*9%1 ^C-5O)#22X5%:;$<<"WJDK3!1*WK>$FT3-Z/SWNA2>1K:W0
MCF(P.7A(OY^"TJ]'LS"-E_7(N6X1L!T"%LQ)Z32.+E@[K]04R *:[08H]LG(
MZY[ F"Y'?N>P/1]-SJ7AR2AH#YK2</)%' :?H-_F1D SFD/-92=HJ:/&ITDG
M^"(,+S\&W<%H/ J&B_9@Y'4&7[UAT#EO?S7F1X/:9D#3<@1)E6P7"X(E8447
M1&PX@HY-RZ2&H4G$5BD8C-0G<Q)OB6GFPBEGA#>,WX7Q \^GT+H%\OD-KW?C
M]48 7C6)J0-FL41D%2NJY&"B$0M;BF4 < U-,Y72OH E39*4-[C^+%P'9-'*
MP^\V%\MOV+TW=EN;V-5-1X0UT+"KNH!=PU:Q!9C%EN#:IN6 ]<Q"7ZJ(!5G4
M#<7\)GP?VK0 ._*90+S#53T+'T7IF,9H,HN]Q/&RN!(8V&!)K]D%O%Q\1D+O
MDG]?,ZP?D*N?D1KU* B\A&7.(*8L4,9Q[WZQ6;;*O7*_C)K!U(^6L.C7I0SJ
M1.5W-^%>X;[)P[E0+\6C?'0Q7G.<F"9)_L\1#$!\E2+\IT(7TJGN&C*1)(HM
M1S=! )LN-@D% 2PZ-A%E5=0L$, B0!3523"=);"XQ+D1/7OY(8JG E0=/G9C
MT(ROT_OZ*3C)IPX1J6N9#M9<6\>*"YK=,!0%$Y=JMJW)E$A&:?\X!OU%TRC<
MQ-'N8T;5KRT35[#=^!A\98^GO/UN:Z6<4EE01$V#Q3$< RNV!;87J$MLFXI"
M)%MS5%$J[7<^W0R5/]$:'4=)2OR1-\V"';_9"GV^/%6(Z3JV*V!-5R2L.)0
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MJE$&<\+6*IR!"HYI2F#T<0:>JY;9W??I$JP9&!-##Z)LX\4F8)%PA"=V[%F
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MWWDC&+-6J[8Q]>8RG+IZ!=<;FSK2:(J"T.@+(F/$<2)BKB<*'HU6T;@B[P#
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MJ5_Y,@0TH#@.12@E"TS563<\-6&>5AND&IQ7HC-79(.LPV)TI>#(.C3TWDJ
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MUKQ@&,;76'6")55.M4$_$X-*@@ZSHU<"_:YU%0![1MO+O[S+9_'I,EOMSDQ
MP3FA4( H(A% 4A# $@1!"#&,5 @9#+"IZ!\;GYK4*WQ>!=#ZL$F+N,.:'D+'
MD95LP825>/M<=I)LR]AH0NUSHR[/WC$.C;7LI\S?L'614U[, Q1)'K( 8+VL
M!XA#"EC,,, 2$D8$% P:G]1N6)Z:'"MPWO<=/(M4VR3,H+OF2L.QVVNF#-@U
MV+J\=>NP-2R-UV+K<J#18^L<8"^\3[DL#YM(C:B\A?B\O/,J_ZB4#N\13(2
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M[CWI7DZ&-Z;;IG]-=[K7Q=X6=?\G!I?F[]?K:YG7"TFD J90$ (4$:X+=(@
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M9BW%[LS7R'HWI<I=\IU,#%=]T^RO$7ZG:[W:[Q[M*/]4KL\I6\@Y#7P61T@
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M8LQ;8<QI-%<L&BVC<6K<W3^/61T&Q+[T/4?KNA/]SK<K;):9Z_\V]45WFO?
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MHSA6UF*MN9ON80HS<2SA*EVR>-Q>!SE#1SIK7?F@\4[ SLD+[%MJH>-BGH#
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M=&EO;F%G<F5E;2YH=&U02P$"% ,4    " "-@O-4PCG3?6,6  !<B   $0
M            @ %#2   :6%R="TR,#(R,#<Q."YH=&U02P$"% ,4    " "-
M@O-4K22F:XD"  "Q"   $0              @ '57@  :6%R="TR,#(R,#<Q
M."YX<V102P$"% ,4    " "-@O-4JKANFNH'  "-.   %0
M@ &-80  :6%R="TR,#(R,#<Q.%]D968N>&UL4$L! A0#%     @ C8+S5%VI
M,[G@"P  CVT  !4              ( !JFD  &EA<G0M,C R,C W,3A?;&%B
M+GAM;%!+ 0(4 Q0    ( (V"\U2AA(YO@@<  (@Z   5              "
M ;UU  !I87)T+3(P,C(P-S$X7W!R92YX;6Q02P$"% ,4    " "-@O-4ER:,
M-%8*  "-/   %P              @ %R?0  <')E<W-R96QE87-E<F5N965L
;;RYH=&U02P4&      < !P#8 0  _8<

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
